Former U.S. Sen. Richard Burr didn’t need very long to transition into a new professional career, joining the global law firm of DLA Piper.
The firm said Tuesday that Burr, of Winston-Salem, will work with the firm’s Regulatory and Government Affairs practice group as a principal policy adviser.
The Republican retired from Congress in January after serving five terms in the U.S. House and three terms in the U.S. Senate.
Under congressional rules, Burr cannot lobby his former Senate colleagues for two years.
Burr spent much of his time in Congress preferring a lower profile even as he took leadership roles in key Senate public health, finance and foreign intelligence committees.
Burr will join the firm with a team of policy advisers that will supplement its legal, policy, economic, medical and technological attorneys and advisers in the health care and life sciences field.
People are also reading…
Among the advisers are Margaret Martin, the committee’s former senior adviser of health policy, and Michael Sorensen, Burr’s former director of operations.
“We are excited to join DLA Piper and help clients navigate the funding, regulation, policy and political landscape of the health care system, from drug development to patient care,” Burr said in a statement.
Burr said his team will provide “unparalleled insight and strategic advice at a time of regulatory and political uncertainty.”
“In addition to the draw of DLA Piper’s strong platform, its expansive global footprint is one of the reasons we chose the firm,” Burr said. “Life sciences is global by every nature, and this allows us to build a roadmap to advise clients no matter where they’re doing business.”
Burr’s duties will include being chairman of the firm’s Health Policy Strategic Consulting practice “to provide policy advice, strategic consulting and a wide range of related services to life